The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study

Table 1

Demographic data and concomitant medication in studied acute STEMI patients.

	T2D group	ND group	Significance
Number of patients (men/women)	21 (11/10)	46 (26/20)	NS
T2D duration (years)	11.4 ± 7.6	—	N/A
HbA1C levels	7.2 ± 1.9%	4.03 ± 0.7%	< 0.001
Age	72 (52–89)	65 (34–88)	NS
Body mass index (kg/m^2)	29.6 ± 4.2	28.6 ± 4.2	NS
Beta blockers (% of patients/number of patients)	90%/19 patients	89%/41 patients	NS
ACE inhibitors or AT1 blockers (% of patients/number of patients)	85%/18 patients	67%/31 patients	NS
Statins (% of patients/number of patients)	100%/21 patients	96%/44 patients	NS
Diuretics (% of patients/number of patients)	52%/11 patients	31%/14 patients	NS
Clopidogrel (% of patients/number of patients)	52%/11 patients	48%/22 patients	NS
Prasugrel (% of patients/number of patients)	48%/10 patients	52%/24 patients	NS